Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Testing the mutant selection window in rabbits infected with methicillin-resistant Staphylococcus aureus exposed to vancomycin.

Zhu YL, Hu LF, Mei Q, Cheng J, Liu YY, Ye Y, Li JB.

J Antimicrob Chemother. 2012 Nov;67(11):2700-6. doi: 10.1093/jac/dks280. Epub 2012 Jul 18.

2.

Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model.

Firsov AA, Smirnova MV, Lubenko IY, Vostrov SN, Portnoy YA, Zinner SH.

J Antimicrob Chemother. 2006 Dec;58(6):1185-92. Epub 2006 Oct 5.

3.

The mutant selection window in rabbits infected with Staphylococcus aureus.

Cui J, Liu Y, Wang R, Tong W, Drlica K, Zhao X.

J Infect Dis. 2006 Dec 1;194(11):1601-8. Epub 2006 Oct 20.

4.

Enrichment of fluoroquinolone-resistant Staphylococcus aureus: oscillating ciprofloxacin concentrations simulated at the upper and lower portions of the mutant selection window.

Firsov AA, Lubenko IY, Smirnova MV, Strukova EN, Zinner SH.

Antimicrob Agents Chemother. 2008 Jun;52(6):1924-8. doi: 10.1128/AAC.01371-07. Epub 2008 Mar 31.

5.

Enrichment of resistant Staphylococcus aureus at ciprofloxacin concentrations simulated within the mutant selection window: bolus versus continuous infusion.

Firsov AA, Smirnova MV, Strukova EN, Vostrov SN, Portnoy YA, Zinner SH.

Int J Antimicrob Agents. 2008 Dec;32(6):488-93. doi: 10.1016/j.ijantimicag.2008.06.031. Epub 2008 Sep 14.

PMID:
18790614
6.

In vitro pharmacodynamic evaluation of the mutant selection window hypothesis using four fluoroquinolones against Staphylococcus aureus.

Firsov AA, Vostrov SN, Lubenko IY, Drlica K, Portnoy YA, Zinner SH.

Antimicrob Agents Chemother. 2003 May;47(5):1604-13.

7.

Telavancin and vancomycin pharmacodynamics with Staphylococcus aureus in an in vitro dynamic model.

Lubenko IY, Strukova EV, Smirnova MV, Vostrov SN, Portnoy YA, Zinner SH, Firsov AA.

J Antimicrob Chemother. 2008 Nov;62(5):1065-9. doi: 10.1093/jac/dkn288. Epub 2008 Jul 17.

8.
10.

In vitro resistance studies with bacteria that exhibit low mutation frequencies: prediction of "antimutant" linezolid concentrations using a mixed inoculum containing both susceptible and resistant Staphylococcus aureus.

Firsov AA, Golikova MV, Strukova EN, Portnoy YA, Romanov AV, Edelstein MV, Zinner SH.

Antimicrob Agents Chemother. 2015 Feb;59(2):1014-9. doi: 10.1128/AAC.04214-14. Epub 2014 Dec 1.

11.

Vancomycin MICs of the resistant mutants of S. aureus ATCC43300 vary based on the susceptibility test methods used.

Zhu YL, Mei Q, Hu LF, Cheng J, Ye Y, Li JB.

J Antibiot (Tokyo). 2012 Jun;65(6):307-10. doi: 10.1038/ja.2012.18. Epub 2012 Apr 11.

PMID:
22491134
12.

Testing the mutant selection window hypothesis with Escherichia coli exposed to levofloxacin in a rabbit tissue cage infection model.

Ni W, Song X, Cui J.

Eur J Clin Microbiol Infect Dis. 2014 Mar;33(3):385-9. doi: 10.1007/s10096-013-1968-8. Epub 2013 Sep 14.

PMID:
24036892
14.

Evaluation of once-daily vancomycin against methicillin-resistant Staphylococcus aureus in a hollow-fiber infection model.

Nicasio AM, Bulitta JB, Lodise TP, D'Hondt RE, Kulawy R, Louie A, Drusano GL.

Antimicrob Agents Chemother. 2012 Feb;56(2):682-6. doi: 10.1128/AAC.05664-11. Epub 2011 Nov 14.

15.

Use of Monte Carlo simulation to evaluate the development of vancomycin resistance in meticillin-resistant Staphylococcus aureus.

Mei Q, Ye Y, Zhu YL, Cheng J, Yang HF, Liu YY, Li HR, Li JB.

Int J Antimicrob Agents. 2015 Jun;45(6):652-6. doi: 10.1016/j.ijantimicag.2015.01.018. Epub 2015 Mar 6.

PMID:
25813394
16.

Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia.

Khatib R, Jose J, Musta A, Sharma M, Fakih MG, Johnson LB, Riederer K, Shemes S.

J Antimicrob Chemother. 2011 Jul;66(7):1594-9. doi: 10.1093/jac/dkr169. Epub 2011 Apr 26.

17.

Testing the mutant selection window hypothesis in vitro and in vivo with Staphylococcus aureus exposed to fosfomycin.

Mei Q, Ye Y, Zhu YL, Cheng J, Chang X, Liu YY, Li HR, Li JB.

Eur J Clin Microbiol Infect Dis. 2015 Apr;34(4):737-44. doi: 10.1007/s10096-014-2285-6. Epub 2014 Nov 26.

PMID:
25424036
18.
19.

[Investigation of reduced vancomycin susceptibility in methicillin-resistant staphylococci].

Kuşcu F, Oztürk DB, Gürbüz Y, Tütüncü EE, Sencan I, Gül S.

Mikrobiyol Bul. 2011 Apr;45(2):248-57. Turkish.

PMID:
21644067
20.
Items per page

Supplemental Content

Write to the Help Desk